Lens cell targeting for gene therapy of prevention of posterior capsule opacification

Gene Therapy

Volumn 13, Issue 19, 2006, Pages 1422-1429

  Malecaze, F ^a   Lubsen, N H ^b   Serre, B ^a   Decha, A ^a   Duboue, M ^a   Penary, M ^c,d   Berg, D ^c,d   Arnaud, J D ^a   Titeux, M ^a   Kremer, E J ^e   Couderc, B ^c,d  

^a INSERM   (France)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

^e INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA CRYSTALLIN; FILENSIN; GAMMA CRYSTALLIN; LENS EPITHELIUM PROTEIN 503; LENS PROTEIN; LENTIVIRUS VECTOR; MACROPHAGE INFLAMMATORY PROTEIN; MATRIGEL; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; AQUAPORIN; AQUAPORIN 0; BETA GALACTOSIDASE; COLLAGEN; CRYSTALLIN; DNA BINDING PROTEIN; EYE PROTEIN; INTERMEDIATE FILAMENT PROTEIN; LAMININ; LENEP PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEOGLYCAN;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATARACT; CONTROLLED STUDY; DRUG SPECIFICITY; DRUG TARGETING; EX VIVO STUDY; FEASIBILITY STUDY; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LENS EPITHELIUM; MOLECULAR CLONING; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROMOTER REGION; RABBIT; REPORTER GENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ADENOVIRUS; ANIMAL; ANTERIOR EYE CHAMBER; DRUG COMBINATION; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETICS; IMMUNOHISTOCHEMISTRY; INJECTION; LENS CAPSULE; METABOLISM; METHODOLOGY; PATHOLOGY; PHASE CONTRAST MICROSCOPY; RECURRENT DISEASE;

ADENOVIRIDAE; LENTIVIRUS; ORYCTOLAGUS CUNICULUS;

ADENOVIRIDAE; AGED; AGED, 80 AND OVER; ANIMALS; ANTERIOR CHAMBER; AQUAPORINS; BETA-GALACTOSIDASE; CATARACT; COLLAGEN; CRYSTALLINS; DNA-BINDING PROTEINS; DRUG COMBINATIONS; EYE PROTEINS; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS; INTERMEDIATE FILAMENT PROTEINS; LAMININ; LENS CAPSULE, CRYSTALLINE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, PHASE-CONTRAST; MODELS, ANIMAL; PROMOTER REGIONS (GENETICS); PROTEOGLYCANS; RABBITS; RECURRENCE; TRANSDUCTION, GENETIC;

EID: 33748870651     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302790     Document Type: Article

References (31)

1. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF et al. Posterior capsule opacification. Surv Ophthalmol 1992; 37: 73-116.
2. Dewey S. Posterior capsule opacification. Curr Opin Ophthalmol 2006; 17: 45-53.
3. De Groot V, Tassignon MJ, Vrensen GF. Effect of bag-in-the-lens implantation on posterior capsule opacification in human donor eyes and rabbit eyes. J Cataract Refract Surg 2005; 31: 398-405.
4. Tassignon MJ, De Groot V, Van Tenten Y. Searching the way out for posterior capsule opacification. Verh K Acad Geneeskd Belg 2005; 67: 277-288.
5. Nishi O. Posterior capsule opacification. Part 1: Experimental investigations. J Cataract Refract Surg 1999; 25: 106-117.
6. Couderc BC, de Neuville S, Douin-Echinard V, Serres B, Manenti S, Darbon JM et al. Retrovirus-mediated transfer of a suicide gene into lens epithelial cells in vitro and in an experimental model of posterior capsule opacification. Curr Eye Res 1999; 19: 472-482.
7. Malecaze F, Couderc B, de Neuville S, Serres B, Mallet J, Douin-Echinard V et al. Adenovirus-mediated suicide gene transduction: Feasibility in lens epithelium and in prevention of posterior capsule opacification in rabbits. Hum Gene Ther 1999; 10: 2365-2372.
8. Malecaze F, Decha A, Serre B, Penary M, Duboue M, Berg D et al. Prevention of posterior capsule opacification by the induction of therapeutic apoptosis of residual lens cells. Gene Therapy 2006; 13: 440-448.
9. Nakamura T, Williams-Simons L, Westphal H. A human papillomavirus type 18 E6/E7 transgene sensitizes mouse lens cells to human wild-type p53-mediated apoptosis. Oncogene 1997; 14: 2991-2998.
10. Hagan III JC. Preventing intraoperative ocular damage. J Cataract Refract Surg 1999; 25: 1177.
11. Chepelinsky AB, Sommer B, Piatigorsky J. Interaction between two different regulatory elements activates the murine alpha A-crystallin gene promoter in explanted lens epithelia. Mol Cell Biol 1987; 7: 1807-1814.
12. Chepelinsky AB, Khillan JS, Mahon KA, Overbeek PA, Westphal H, Piatigorsky J. Crystallin genes: Lens specificity of the murine alpha A-crystallin gene. Environ Health Perspect 1987; 75: 17-24.
13. Sax CM, Cvekl A, Piatigorsky J. Transcriptional regulation of the mouse alpha A-crystallin gene: Binding of USF to the -7/+5 region. Gene 1997; 185: 209-216.
14. Klok EJ, van Genesen ST, Civil A, Schoenmakers JG, Lubsen NH. Regulation of expression within a gene family. The case of the rat gammaB- and gammaD-crystallin promoters. J Biol Chem 1998; 273: 17206-17215.
15. Heon E, Priston M, Schorderet DF, Billingsley GD, Girard PO, Lubsen N et al. The gamma-crystallins and human cataracts: A puzzle made clearer. Am J Hum Genet 1999; 65: 1261-1267.
16. Golestaneh N, Fan J, Fariss RN, Lo WK, Zelenka PS, Chepelinsky AB. Lens major intrinsic protein (MIP)/aquaporin 0 expression in rat lens epithelia explants requires fibroblast growth factor-induced ERK and JNK signaling. J Biol Chem 2004; 279: 31813-31822.
17. Kim S, Ge H, Ohtaka-Maruyama C, Chepelinsky AB. The transcription factor Sp3 interacts with promoter elements of the lens specific MIP gene. Mol Vis 1999; 5: 12.
18. Wang XY, Ohtaka-Maruyama C, Pisano MM, Jaworski CJ, Chepelinsky AB. Isolation and characterization of the 5′-flanking sequence of the human ocular lens MIP gene. Gene 1995; 167: 321-325.
19. Wen Y, Sachs G, Athmann C. A novel lens epithelium gene, LEP503, is highly conserved in different vertebrate species and is developmentally regulated in postnatal rat lens. Exp Eye Res 2000; 70: 159-168.
20. Wen Y, Ibaraki N, Reddy VN, Sachs G. Functional analysis of the promoter and chromosomal localization for human LEP503, a novel lens epithelium gene. Gene 2001; 269: 61-71.
21. Lim JM, Cho KH. Prediction of gene expression levels and the role of cis-acting elements in age-related cataract by applying a promoter-based modeling approach. Biotechnol Prog 2005; 21: 1032-1037.
22. DePianto DJ, Blankenship TN, Hess JF, FitzGerald PG. Analysis of non-crystallin lens fiber cell gene expression in c-Maf -/- mice. Mol Vis 2003; 9: 288-294.
23. Masaki S, Yonezawa S, Quinlan R. Localization of two conserved cis -acting enhancer regions for the filensin gene promoter that direct lens-specific expression. Exp Eye Res 2002; 75: 295-305.
24. Krag S, Andreassen TT. Mechanical properties of the human lens capsule. Prog Retin Eye Res 2003; 22: 749-767.
25. Krag S, Andreassen TT. Mechanical properties of the human posterior lens capsule. Invest Ophthalmol Vis Sci 2003; 44: 691-696.
26. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994; 371: 72-74.
27. Horwitz J, Bova MP, Ding LL, Haley DA, Stewart PL. Lens alpha-crystallin: Function and structure. Eye 1999; 13 (Part 3b): 403-408.
28. Ilagan JG, Cvekl A, Kantorow M, Piatigorsky J, Sax CM. Regulation of alphaA-crystallin gene expression. Lens specificity achieved through the differential placement of similar transcriptional control elements in mouse and chicken. J Biol Chem 1999; 274: 19973-19978.
29. Overbeek PA, Chepelinsky AB, Khillan JS, Piatigorsky J, Westphal H. Lens-specific expression and developmental regulation of the bacterial chloramphenicol acetyltransferase gene driven by the murine alpha A-crystallin promoter in transgenic mice. Proc Natl Acad Sci USA 1985; 82: 7815-7819.
30. Chen Q, Ash JD, Branton P, Fromm L, Overbeek PA. Inhibition of crystallin expression and induction of apoptosis by lens-specific E1A expression in transgenic mice. Oncogene 2002; 21: 1028-1037.
31. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.